David A. Siegel Pacira Bio Sciences, Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$25.5 - $31.51 $1.62 Million - $2 Million	-63,500 Reduced 69.63%	27,700 $792,000
Q1 2024 May 15, 2024	BUY	$27.7 - $35.48 $263,150 - $337,059	9,500 Added 11.63%	91,200 $2.66 Million
Q4 2023 Feb 14, 2024	SELL	$26.32 - $34.31 $947,520 - $1.24 Million	-36,000 Reduced 30.59%	81,700 $2.76 Million
Q3 2023 Nov 14, 2023	BUY	$30.68 - $40.09 $1.35 Million - $1.77 Million	44,100 Added 59.92%	117,700 $3.61 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $47.5 $2.19 Million - $2.88 Million	60,700 Added 470.54%	73,600 $2.95 Million
Q1 2023 May 15, 2023	BUY	$35.53 - $43.38 $458,337 - $559,602	12,900 New	12,900 $526,000
Q2 2022 Aug 15, 2022	SELL	$51.49 - $81.64 $863,796 - $1.37 Million	-16,776 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$60.03 - $76.49 $3.67 Million - $4.68 Million	-61,200 Reduced 78.49%	16,776 $1.28 Million
Q4 2021 Feb 14, 2022	SELL	$47.97 - $62.21 $6.13 Million - $7.94 Million	-127,700 Reduced 62.09%	77,976 $4.69 Million
Q3 2021 Nov 15, 2021	SELL	$54.64 - $61.3 $8.28 Million - $9.29 Million	-151,600 Reduced 42.43%	205,676 $11.5 Million
Q2 2021 Aug 16, 2021	BUY	$59.18 - $69.99 $18 Million - $21.3 Million	303,700 Added 566.86%	357,276 $21.7 Million
Q1 2021 May 17, 2021	BUY	$59.31 - $78.82 $1.59 Million - $2.11 Million	26,800 Added 100.09%	53,576 $3.76 Million
Q4 2020 Feb 16, 2021	BUY	$50.47 - $66.26 $105,987 - $139,146	2,100 Added 8.51%	26,776 $1.6 Million
Q3 2020 Nov 16, 2020	BUY	$51.97 - $63.0 $1.28 Million - $1.55 Million	24,676 New	24,676 $1.48 Million
Q2 2020 Aug 14, 2020	SELL	$30.8 - $52.47 $254,900 - $434,241	-8,276 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$28.4 - $50.7 $1.36 Million - $2.42 Million	-47,800 Reduced 85.24%	8,276 $277,000
Q4 2019 Feb 14, 2020	SELL	$36.31 - $46.83 $232,384 - $299,712	-6,400 Reduced 10.24%	56,076 $2.54 Million
Q3 2019 Nov 14, 2019	SELL	$35.66 - $44.99 $7.97 Million - $10.1 Million	-223,500 Reduced 78.15%	62,476 $2.38 Million
Q2 2019 Aug 14, 2019	BUY	$36.57 - $47.97 $1.69 Million - $2.22 Million	46,200 Added 19.27%	285,976 $12.4 Million
Q1 2019 May 15, 2019	SELL	$36.47 - $42.17 $1.12 Million - $1.29 Million	-30,600 Reduced 11.32%	239,776 $9.13 Million
Q4 2018 Feb 14, 2019	BUY	$41.31 - $52.16 $4.85 Million - $6.13 Million	117,500 Added 76.86%	270,376 $11.6 Million
Q3 2018 Nov 14, 2018	BUY	$32.85 - $52.0 $5.02 Million - $7.95 Million	152,876 New	152,876 $7.51 Million
Q1 2018 May 15, 2018	SELL	$29.98 - $46.35 $6.63 Million - $10.2 Million	-221,076 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$31.85 - $46.95 $6.35 Million - $9.36 Million	199,376 Added 918.78%	221,076 $10.1 Million
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $774,690 - $857,150	21,700	21,700 $815,000

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

Black Rock Inc. New York, NY

8.01M
Shares

$156 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.3M
Shares

$103 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

4.96M
Shares

$96.6 Million
0.18% of portfolio
State Street Corp Boston, MA

2.01M
Shares

$39.2 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.98M
Shares

$38.5 Million
0.05% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account